Category: News

Reliving the commitment and mission, Bio-Labs added a new product to its inventory. Bio-Labs is both gratified and proud to launch Merobio (Meropenem) recently with one and only aim that is VALUING LIFE.

Merobio (Meropenem) is not only a lifesaving drug but is only one of a few antibiotics that are putting up a sturdy fight against superbugs. From Elderly patients to Infants to Females with complicated infections Merobio (Meropenem) is the answer of this era.

Merobio Launch event was made special by the presence of the whole Bio-Labs’ team, senior doctors, Mentors, Motivational speakers, Life coaches and nutritional experts.

Bio-Labs is proud to be the first pharmaceutical company in Pakistan to launch the breakthrough new drug for COVID, Molnupiravir capsules, under the brand name of MOLNUCAP for export markets. After RIVONA injection (Remdesivir) and FAVILAB tablets (Favipiravir) successful launches, this is another feather in the cap of Bio-Labs for bringing the newest medicines to combat the COVID pandemic for patients globally.

Bio-Labs received the “Leading Pandemic Healthcare & Pharmaceutical Company Award” in recognition of the provision of breakthrough therapies during the COVID-19 pandemic at the RCCI 33rd International Achievement Awards 2021 held in Colombo, Sri Lanka in November, 2021. This award was presented by the Honorable Prime Minister of Sri Lanka, H.E. Mahinda Rajapaksa.

Bio-labs’ Rivona (Remdesivir) is the most successful antiviral drug for the treatment of COVID-19 not only in Pakistan but globally.

Colombo, Sri Lanka: Bio-Labs signed several MOUs with leading Sri Lankan pharmaceutical entities for joint ventures during the recent RCCI Business Opportunities Conference held in Colombo, Sri Lanka in November, 2021. Trade Minister of Sri Lanka, Dr. Bandula Gunawardhana was the Chief Guest of the ceremony